Skip to main content

Bellerophon Therapeutics, Inc.

BLPHDelisted Dec 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001600132

Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.

Q1 2023 vs. Q4 2022

How the institutions holding Bellerophon Therapeutics, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of BLPH: Q4 2022 compared with Q1 2023
MeasureQ4 2022Of which not filed for Q1 2023Q1 2023Change
Holders25119−5
Shares925.5K44.0K3.53M+2.65M (+300.8%)
Value$832.7K$40.0K$27.9M+$27.1M (+3,416.7%)

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Bellerophon Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to BLPH in Q1 2023
InstitutionSharesValue% of portfolio
Perceptive Advisors LLC930,000$7.34M0.22%
Tang Capital Management LLC893,974$7.05M1.05%
Dimensional Fund Advisors LP13,585$107.2K0.00%
Proequities, Inc.40$3150.00%

Sold out (9)

Institutions that held Bellerophon Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of BLPH in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
HRT Financial LP28,035$25.0K
Sepio Capital, LP23,800$21.4K
Millennium Management LLC22,944$21.0K
Tudor Investment Corp Et Al20,000$18.0K
Ergoteles LLC14,891$13.4K
Jane Street Group, LLC13,762$12.4K
UBS Group AG2,297$2.07K
JPMorgan Chase & Co100$0
Sofos Investments, Inc.1–

Not filed for Q1 2023 yet (1)

Institutions that held Bellerophon Therapeutics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BLPH in Q4 2022 that haven't filed for Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Telemetry Investments, L.L.C.44,000$40.0K